REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,738 | -43.1% | 243,442 | -45.0% | 0.02% | -40.0% |
| Q2 2023 | $11,835 | +23.5% | 442,442 | 0.0% | 0.02% | +8.7% |
| Q1 2023 | $9,583 | -14.9% | 442,442 | -6.5% | 0.02% | -14.8% |
| Q4 2022 | $11,267 | -99.9% | 473,003 | -0.8% | 0.03% | +8.0% |
| Q3 2022 | $9,404,000 | +10.1% | 476,850 | +8.9% | 0.02% | +19.0% |
| Q2 2022 | $8,538,000 | -23.6% | 438,054 | 0.0% | 0.02% | -8.7% |
| Q1 2022 | $11,175,000 | +1.4% | 438,054 | 0.0% | 0.02% | +4.5% |
| Q4 2021 | $11,026,000 | -8.5% | 438,054 | 0.0% | 0.02% | -15.4% |
| Q3 2021 | $12,051,000 | -13.3% | 438,054 | 0.0% | 0.03% | -13.3% |
| Q2 2021 | $13,904,000 | -30.8% | 438,054 | 0.0% | 0.03% | -37.5% |
| Q1 2021 | $20,098,000 | -7.9% | 438,054 | -20.5% | 0.05% | -15.8% |
| Q4 2020 | $21,824,000 | -7.2% | 551,251 | -18.4% | 0.06% | -17.4% |
| Q3 2020 | $23,505,000 | +10.2% | 675,418 | 0.0% | 0.07% | +3.0% |
| Q2 2020 | $21,323,000 | +44.1% | 675,418 | 0.0% | 0.07% | +11.7% |
| Q1 2020 | $14,798,000 | – | 675,418 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |